and price. …

pharmaceutical pricing. The 2018 OECD report Pharmaceutical Innovation and Access to Medicines suggested that increased price … policy debate, the OECD undertook an exploration of the potential consequences of greater price transparency on market …

, given relatively high demand elasticities for pharmaceuticals in these populations; modest cash resources for health care …

This paper reports the results from a statistical analysis of pharmaceutical price negotiations in Germany, where the … pricing system was changed in 2011 in order to tie prices more to the benefits of the pharmaceuticals. A multiple linear … regression of 187 pharmaceuticals which were assessed from 2011 to 2017 suggests that, despite the change, the manufacturers …